Establishing Individual Patient Risk for Progression to Esophageal Cancer
Moderated by Dr. Sri Komanduri, panelists Dr. Vani Konda and Dr. Rhonda Souza discuss individual risk for the development of high-grade dysplasia (HGD) and/or esophageal adenocarcinoma (EAC) in Barrett’s esophagus (BE) patients. The panelists explore the problem of determining who to treat and who to surveil and the unmet need in the market. Learn the impact on patient care and the GI practice of implementing a test that identifies individual risk for progression to HGD/EAC, regardless of histological grade or other clinical factors. Hear what TissueCypher® is, how it works and the information it provides.
Cernostics, Esophageal Cancer, Risk Stratification, HGD/EAC, BE, Barrett's, Barrett's Esophagus, TissueCypher, Tissue Cypher, Barrett’s Esophagus Assay, dysplasia, high grade dysplasia, HGD, esophageal adenocarcinoma, EAC, Sri Komanduri, Vani Konda, Rhonda Souza, BE patients with No Dysplasia, ND, BE patients Indefinite for Dysplasia, IND, BE patients with Low-Grade Dysplasia, No Dysplasia, ND, Indefinite for Dysplasia, IND, Low-Grade Dysplasia, LGD, Dr. Sri Komanduri, Dr Sri Komanduri, Dr. Komanduri, Dr Komanduri, Dr. Vani Konda, Dr Vani Konda, Dr. Konda, Dr Konda, Dr. Rhonda Souza, Dr Rhonda Souza, Dr. Souza, Dr Souza, VirtualEd, replay
Other Featured Videos
Improving Detection Rates in Modern Colonoscopy: Utilizing Latest Technologies to Exceed Quality Metrics
March 18, 2026
Olympus
Dr. John Guardiola discusses strategies to improve detection rates in modern colonoscopy using advanced technologies. Dr. Guardiola covers the evolution of adenoma detection rates (ADR), factors influencing detection, texture and color enhancement options, and techniques to improve detection. Explore how to improve ADR and sessile serrated lesion detection rate (SSLDR) in your practice.
Clinical Practice Update: Implementing Single-use Duodenoscopes Into Your Practice, A Clinical Practice Model
July 16, 2025
ENow Solutions
A peer discussion on how and why to incorporate single-use duodenoscopes into your practice. Understand indications, technical considerations, reimbursement, and developing referral patterns for single-use duodenoscopes. See a review and discussion of patient cases.
Reprocessing Effectiveness: A Reality Check for Reusable Duodenoscopes
August 26, 2025
Boston Scientific EDUCARE
Cori Ofstead, CEO of Ofstead & Associates, Inc., and Betty McGinty of Boston Scientific present eye-opening data and examples of the current state of scope reprocessing effectiveness. Viewers will hear how to establish core quality management guidelines for endoscope safety and the prevention of patient infections and exposures. Learn practical solutions for reprocessing effectiveness.
